Lipocine Inc. Common Stock (LPCN)

About LPCN

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression; LPCN 1148, a prodrug of tes…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

14

Website

www.lipocine.com/

Fundamentals

1-day range

$2.13$2.22

Market cap

$17.40M

P/E (trailing)

—

P/E (forward)

-1.75

EPS (trailing)

$-1.96

Dividend yield

—

Beta

0.36

Avg. volume

62.2K

Forecasts

1 analyst ratings

Lipocine Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• LPCN

  Lipocine Inc. Common Stock

  $2.2

  ▼ 1.35%
  Market cap $17.40MP/E —
  $1.81$12.37
• NRSN

  NeuroSense Therapeutics Ltd. Ordinary Shares

  $0.4301

  ▼ 2.03%
  Market cap $17.64MP/E —
  $0.25$1.98
• RKTO

  Rocket One Inc. Common Stock

  $0.7021

  ▼ 2.76%
  Market cap $17.64MP/E —
  $0.691501$2.45
• OPTH

  Optimi Health Corp. Common Shares

  $4.93

  ▼ 0.80%
  Market cap $16.61MP/E —
  $0.195$11.4
• MDCX

  Medicus Pharma Ltd. Common Stock

  $0.258

  ▼ 3.73%
  Market cap $16.60MP/E —
  $0.2425$3.05
• NCEL

  NewcelX Ltd. Ordinary Shares

  $3.19

  ▼ 6.73%
  Market cap $18.41MP/E —
  $1.83$24.6
• DARE

  Dare Bioscience Inc. Common Stock

  $0.7437

  ▲ 0.64%
  Market cap $19.17MP/E —
  $0.72$3.78

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
  Yahoo · 8/4/2026
• Lipocine Q2 EPS $(0.32) Beats $(0.43) Estimate, Sales $190.099K Beat $156.500K Estimate
  Benzinga · 8/4/2026
• Lipocine Appoints Michael J. Grissinger to Board of Directors
  Yahoo · 8/3/2026

• Michael Grissinger · August 3, 2026 · Grant

  2.0K @ $2.11
• John W. Higuchi · June 3, 2026 · Grant

  1.8K @ $2.19
• Jene Jill M. · June 3, 2026 · Grant

  1.8K @ $2.19
• Richard Dana Ono · June 3, 2026 · Grant

  1.8K @ $2.19
• John W. Higuchi · April 7, 2026 · Buy

  40.0K @ $2.03
• John W. Higuchi · April 6, 2026 · Buy

  123.0K @ $2.05
• Mahesh Patel V · April 6, 2026 · Buy

  25.0K @ $2.03
• Mahesh Patel V · April 2, 2026 · Buy

  25.0K @ $2.02

Institutional Ownership

March 31, 2026

Total shares held

3.08M

Total value held

$24.64M

Institutional holders

44